BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24053688)

  • 1. Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular basement membrane disease.
    Hu SY; Jia XY; Yang XW; Yu F; Cui Z; Zhao MH
    BMC Immunol; 2013 Sep; 14():42. PubMed ID: 24053688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.
    Trouw LA; Groeneveld TW; Seelen MA; Duijs JM; Bajema IM; Prins FA; Kishore U; Salant DJ; Verbeek JS; van Kooten C; Daha MR
    J Clin Invest; 2004 Sep; 114(5):679-88. PubMed ID: 15343386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity.
    Cui Z; Zhao MH
    Clin Immunol; 2005 Jul; 116(1):77-82. PubMed ID: 15925834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis.
    Tan Y; Song D; Wu LH; Yu F; Zhao MH
    BMC Nephrol; 2013 Mar; 14():63. PubMed ID: 23510032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic significance of glomerular C1q deposits in primary MN.
    Zhang MF; Cui Z; Zhang YM; Qu Z; Wang X; Wang F; Meng LQ; Cheng XY; Liu G; Zhao MH
    Clin Chim Acta; 2018 Oct; 485():152-157. PubMed ID: 29969623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies.
    Trouw LA; Seelen MA; Duijs JM; Benediktsson H; Van Kooten C; Daha MR
    Clin Exp Immunol; 2003 Apr; 132(1):32-9. PubMed ID: 12653833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell infiltration is associated with kidney injury in patients with anti-glomerular basement membrane disease.
    Hu SY; Jia XY; Li JN; Zheng X; Ao J; Liu G; Cui Z; Zhao MH
    Sci China Life Sci; 2016 Dec; 59(12):1282-1289. PubMed ID: 27080546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against C1q in anti-glomerular basement membrane nephritis.
    Coremans IE; Daha MR; van der Voort EA; Muizert Y; Halma C; Breedveld FC
    Clin Exp Immunol; 1992 Feb; 87(2):256-60. PubMed ID: 1735189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The heterogeneity of anti-GBM autoantibodies in sera from patients with anti-GBM disease and its clinical correlation].
    Liu C; Qu Z; Yang R; Zhao J; Jia XY; Zheng X; Liu ZS; Cui Z; Zhao MH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 41(6):625-9. PubMed ID: 20019770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease.
    Ma R; Cui Z; Hu SY; Jia XY; Yang R; Zheng X; Ao J; Liu G; Liao YH; Zhao MH
    PLoS One; 2014; 9(3):e91250. PubMed ID: 24658070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis.
    van Daalen EE; Jennette JC; McAdoo SP; Pusey CD; Alba MA; Poulton CJ; Wolterbeek R; Nguyen TQ; Goldschmeding R; Alchi B; Griffiths M; de Zoysa JR; Vincent B; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):63-72. PubMed ID: 29162595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis.
    Weber MF; Andrassy K; Pullig O; Koderisch J; Netzer K
    J Am Soc Nephrol; 1992 Jan; 2(7):1227-34. PubMed ID: 1317224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
    Zhao M; Ding J; Liu Y; Zou W; Wang H
    Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort.
    Alchi B; Griffiths M; Sivalingam M; Jayne D; Farrington K
    Nephrol Dial Transplant; 2015 May; 30(5):814-21. PubMed ID: 25609740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.
    Cui Z; Zhao J; Jia XY; Zhu SN; Zhao MH
    Am J Kidney Dis; 2011 Apr; 57(4):575-82. PubMed ID: 21168945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between anti-C1q antibodies and glomerular tuft necrosis in lupus nephritis.
    Jourde-Chiche N; Daniel L; Chiche L; Burtey S; Mancini J; Jego S; San Marco M; Bardin N
    Clin Nephrol; 2012 Mar; 77(3):211-8. PubMed ID: 22377252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease.
    Cui Z; Zhao MH; Xin G; Wang HY
    Nephron Clin Pract; 2005; 99(2):c49-55. PubMed ID: 15637429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation.
    O'Flynn J; Flierman R; van der Pol P; Rops A; Satchell SC; Mathieson PW; van Kooten C; van der Vlag J; Berden JH; Daha MR
    Mol Immunol; 2011 Oct; 49(1-2):75-83. PubMed ID: 21855148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury.
    Jia XY; Cui Z; Yang R; Hu SY; Zhao MH
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):926-33. PubMed ID: 22461538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.